Influence of diethylaminoethyl-dextran on uptake and degradation of polyoma virus deoxyribonucleic acid by mouse embryo cells.
The uptake of (32)P-labeled polyoma virus deoxyribonucleic acid (DNA) (I and II + III) by mouse embryo cells was increased from two- to fivefold in the presence of 500 mug of diethylaminoethyl-dextran (DEAE-D) per ml. This concentration of DEAE-D gives maximal enhancement of infectivity; however, the increase is many thousand-fold. As the DEAE-D concentration was increased from 0 mug/ml, uptake and infectivity increased to flat maxima and then decreased in a similar manner, except that at low DEAE-D concentrations uptake was relatively much greater than infectivity. Several other polycations also increased DNA uptake but did not enhance infectivity, and uptake of viral DNA was unaffected by the presence of mouse DNA, although infectivity was reduced. Thus, increased uptake is not the sole basis for the enhancement of infectivity produced by DEAE-D. The possibilities that DNA complexed with DEAE-D penetrates more rapidly or is stabilized against degradation do not completely account for enhancement since complexes formed in mixtures of DNA and DEAE-D, which sedimented heterogeneously from 40 to 60S, were infectious only for monolayers treated with DEAE-D. A more likely factor in enhancement is inhibition of the cellular nuclease activity detected, since virus DNA exposed to cells was much more degraded in the absence than in the presence of DEAE-D. The nuclease activity produced single-strand breaks in double-stranded DNA. Treatment of monolayers with deoxyribonuclease after adsorption of DNA in the presence of DEAE-D reduced cell-associated radioactivity by about 70%, although the number of plaques formed was not affected. In the absence of DEAE-D, 90 to 100% was removed by deoxyribonuclease. Thus, in both cases most of the DNA was adsorbed extracellularly. The greater deoxyribonuclease-resistant fraction in the presence of DEAE-D would be consistent with another possibility: that enhancement results from an increase in DNA penetration rate due to some action of DEAE-D on the cell.
D000327:Adsorption; D000818:Animals; D002499:Centrifugation, Density Gradient; D004247:DNA / Q000378:metabolism; D004279:DNA, Viral / Q000378:metabolism*; D003851:Deoxyribonucleases / Q000494:pharmacology; D003911:Dextrans / Q000494:pharmacology*; D004622:Embryo, Mammalian / Q000378:metabolism*; D066298:In Vitro Techniques; D008239:Lysine / Q000494:pharmacology; D051379:Mice; D009952:Ornithine / Q000494:pharmacology; D010179:Pancreas; D010759:Phosphorus Isotopes; D011120:Polyomavirus / Q000378:metabolism*; D011877:Radionuclide Imaging; D013997:Time Factors
D004279:DNA, Viral; D003911:Dextrans; D010759:Phosphorus Isotopes; D004247:DNA; D009952:Ornithine; D003851:Deoxyribonucleases; D008239:Lysine